Copyright Reports & Markets. All rights reserved.

Global Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Monotherapy
      • 1.4.3 Combination Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2025)
      • 1.5.2 Medical Research Institution
      • 1.5.3 Hospital and Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Synthetic Lethality-based Drugs and Targets Market Size
    • 2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Regions
      • 2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Regions (2019-2025)
      • 2.2.2 Synthetic Lethality-based Drugs and Targets Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Synthetic Lethality-based Drugs and Targets Market Size by by Players
      • 3.1.1 Global Synthetic Lethality-based Drugs and Targets Revenue by by Players (2014-2019)
      • 3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
    • 3.2 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served
    • 3.3 Key Players Synthetic Lethality-based Drugs and Targets Product/Solution/Service
    • 3.4 Date of Enter into Synthetic Lethality-based Drugs and Targets Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2014-2019)
    • 4.2 Global Synthetic Lethality-based Drugs and Targets Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2014-2019)
    • 5.2 Synthetic Lethality-based Drugs and Targets Key Players in North America
    • 5.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Type
    • 5.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Application

    6 Europe

    • 6.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2014-2019)
    • 6.2 Synthetic Lethality-based Drugs and Targets Key Players in Europe
    • 6.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type
    • 6.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application

    7 China

    • 7.1 China Synthetic Lethality-based Drugs and Targets Market Size (2014-2019)
    • 7.2 Synthetic Lethality-based Drugs and Targets Key Players in China
    • 7.3 China Synthetic Lethality-based Drugs and Targets Market Size by Type
    • 7.4 China Synthetic Lethality-based Drugs and Targets Market Size by Application

    8 Japan

    • 8.1 Japan Synthetic Lethality-based Drugs and Targets Market Size (2014-2019)
    • 8.2 Synthetic Lethality-based Drugs and Targets Key Players in Japan
    • 8.3 Japan Synthetic Lethality-based Drugs and Targets Market Size by Type
    • 8.4 Japan Synthetic Lethality-based Drugs and Targets Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size (2014-2019)
    • 9.2 Synthetic Lethality-based Drugs and Targets Key Players in Southeast Asia
    • 9.3 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size by Type
    • 9.4 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size by Application

    10 India

    • 10.1 India Synthetic Lethality-based Drugs and Targets Market Size (2014-2019)
    • 10.2 Synthetic Lethality-based Drugs and Targets Key Players in India
    • 10.3 India Synthetic Lethality-based Drugs and Targets Market Size by Type
    • 10.4 India Synthetic Lethality-based Drugs and Targets Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Synthetic Lethality-based Drugs and Targets Market Size (2014-2019)
    • 11.2 Synthetic Lethality-based Drugs and Targets Key Players in Central & South America
    • 11.3 Central & South America Synthetic Lethality-based Drugs and Targets Market Size by Type
    • 11.4 Central & South America Synthetic Lethality-based Drugs and Targets Market Size by Application

    12 International Players Profiles

    • 12.1 AbbVie
      • 12.1.1 AbbVie Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019))
      • 12.1.5 AbbVie Recent Development
    • 12.2 AstraZeneca
      • 12.2.1 AstraZeneca Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.2.5 AstraZeneca Recent Development
    • 12.3 BeiGene
      • 12.3.1 BeiGene Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.3.5 BeiGene Recent Development
    • 12.4 Clovis Oncology
      • 12.4.1 Clovis Oncology Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.4.5 Clovis Oncology Recent Development
    • 12.5 GlaxoSmithKline
      • 12.5.1 GlaxoSmithKline Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.5.5 GlaxoSmithKline Recent Development
    • 12.6 Pfizer
      • 12.6.1 Pfizer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.6.5 Pfizer Recent Development
    • 12.7 AtlasMedx
      • 12.7.1 AtlasMedx Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.7.5 AtlasMedx Recent Development
    • 12.8 Chordia Therapeutics
      • 12.8.1 Chordia Therapeutics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.8.5 Chordia Therapeutics Recent Development
    • 12.9 IDEAYA Biosciences
      • 12.9.1 IDEAYA Biosciences Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.9.5 IDEAYA Biosciences Recent Development
    • 12.10 Mission Therapeutics
      • 12.10.1 Mission Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Synthetic Lethality-based Drugs and Targets Introduction
      • 12.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2014-2019)
      • 12.10.5 Mission Therapeutics Recent Development
    • 12.11 Repare Therapeutics
    • 12.12 Sierra Oncology
    • 12.13 SyntheX Labs

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Synthetic Lethality-based Drugs and Targets status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Synthetic Lethality-based Drugs and Targets development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AbbVie
      AstraZeneca
      BeiGene
      Clovis Oncology
      GlaxoSmithKline
      Pfizer
      AtlasMedx
      Chordia Therapeutics
      IDEAYA Biosciences
      Mission Therapeutics
      Repare Therapeutics
      Sierra Oncology
      SyntheX Labs

      Market segment by Type, the product can be split into
      Monotherapy
      Combination Therapy

      Market segment by Application, split into
      Medical Research Institution
      Hospital and Clinic
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Synthetic Lethality-based Drugs and Targets status, future forecast, growth opportunity, key market and key players.
      To present the Synthetic Lethality-based Drugs and Targets development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Synthetic Lethality-based Drugs and Targets are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now